Literature DB >> 4066040

Trehalose dimycolate from various mycobacterial species induces differing anti-infectious activities in combination with muramyl dipeptide.

K N Masihi, W Brehmer, W Lange, H Werner, E Ribi.   

Abstract

Significant resistance against influenza virus and Mycobacterium tuberculosis infections was induced when trehalose dimycolate from M. tuberculosis or M. bovis but not M. avium was combined with muramyl dipeptide. Trehalose dimycolate from M. tuberculosis, in contrast to that from M. avium, could confer resistance against Toxoplasma gondii infections.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4066040      PMCID： PMC261175          DOI： 10.1128/iai.50.3.938-940.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  12 in total

1.  Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives.

Authors:  F Ellouz; A Adam; R Ciorbaru; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1974-08-19       Impact factor: 3.575

Review 2.  Microparticulate gel chromatography accelerated by centrifugal force and pressure.

Authors:  E Ribi; R Parker; K Milner
Journal:  Methods Biochem Anal       Date:  1974

Review 3.  Immunoreactive substances of mycobacteria.

Authors:  M B Goren
Journal:  Am Rev Respir Dis       Date:  1982-03

4.  Chemiluminescence response of peritoneal exudate cells from mice infected with virulent and avirulent strains of Toxoplasma gondii.

Authors:  K N Masihi; H Werner; K E Gillert; W Lange
Journal:  Parasite Immunol       Date:  1984-05       Impact factor: 2.280

5.  Separation of the mixture of trehalose 6,6'-dimycolates comprising the mycobacterial glycolipid fraction, "P3".

Authors:  S M Strain; R Toubiana; E Ribi; R Parker
Journal:  Biochem Biophys Res Commun       Date:  1977-07-25       Impact factor: 3.575

6.  Protective effect of muramyl dipeptide analogs in combination with trehalose dimycolate against aerogenic influenza virus and Mycobacterium tuberculosis infections in mice.

Authors:  K N Masihi; W Brehmer; W Lange; E Ribi; S Schwartzman
Journal:  J Biol Response Mod       Date:  1984-12

7.  Effects of mycobacterial fractions and muramyl dipeptide on the resistance of mice to aerogenic influenza virus infection.

Authors:  K N Masihi; W Brehmer; W Lange; E Ribi
Journal:  Int J Immunopharmacol       Date:  1983

8.  Stimulation of chemiluminescence and resistance against aerogenic influenza virus infection by synthetic muramyl dipeptide combined with trehalose dimycolate.

Authors:  K N Masihi; W Brehmer; I Azuma; W Lange; S Müller
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

9.  Factors influencing protection against experimental tuberculosis in mice by heat-stable cell wall vaccines.

Authors:  E Ribi; R L Anacker; W Brehmer; G Goode; C L Larson; R H List; K C Milner; W C Wicht
Journal:  J Bacteriol       Date:  1966-10       Impact factor: 3.490

10.  Regression of tumors in guinea pigs after treatment with synthetic muramyl dipeptides and trehalose dimycolate.

Authors:  C A McLaughlin; S M Schwartzman; B L Horner; G H Jones; J G Moffatt; J J Nestor; D Tegg
Journal:  Science       Date:  1980-04-25       Impact factor: 47.728
View more
  4 in total

Review 1.  Immunological study of the defined constituents of mycobacteria.

Authors:  J Ivanyi; K Sharp; P Jackett; G Bothamley
Journal:  Springer Semin Immunopathol       Date:  1988

2.  Identification of valine- or leucine-containing glycopeptidolipids from Mycobacterium avium-intracellulare complex.

Authors:  Naoya Ichimura; Takeshi Kasama
Journal:  Curr Microbiol       Date:  2012-03-22       Impact factor: 2.188

3.  Mycobacterial trehalose dimycolate reprograms macrophage global gene expression and activates matrix metalloproteinases.

Authors:  Kaori Sakamoto; Mi Jeong Kim; Elizabeth R Rhoades; Rachel E Allavena; Sabine Ehrt; Helen C Wainwright; David G Russell; Kyle H Rohde
Journal:  Infect Immun       Date:  2012-12-21       Impact factor: 3.441

4.  Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide.

Authors:  François Coulombe; Maziar Divangahi; Frédéric Veyrier; Louis de Léséleuc; James L Gleason; Yibin Yang; Michelle A Kelliher; Amit K Pandey; Christopher M Sassetti; Michael B Reed; Marcel A Behr
Journal:  J Exp Med       Date:  2009-07-06       Impact factor: 14.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.